Multiplex qPCR vs. Singleplex qPCR: Key Differences, Benefits, and Experimental Considerations
Exhibitor: MEDCLUB SCIENTIFIC CO., LTD.
Date: 2026-05-12
Booth No.: L1025
Real-time quantitative PCR (qPCR) has significantly improved the efficiency of nucleic acid detection and quantitative analysis. It offers high sensitivity, rapid detection, and strong application flexibility. Many real-time PCR experiments detect only one target in each reaction well; this approach is known as singleplex qPCR.
Multiplex qPCR further enhances the efficiency of real-time PCR analysis. In a multiplex qPCR reaction, multiple independent target sequences can be amplified and detected simultaneously within the same reaction well. This allows researchers to obtain more analytical data with fewer reactions, while improving reagent efficiency and experimental consistency.
Whether used for gene expression analysis or pathogen detection, multiplex qPCR can effectively simplify experimental workflows.
From Singleplex to Multiplex: How It Works
A typical real-time PCR reaction usually contains a pair of primers. When using the TaqMan™ probe-based method, a fluorescently labeled probe is also included in the reaction. In a singleplex qPCR experiment, each reaction well typically amplifies and detects only one target sequence.
In multiplex qPCR, two or more targets can be amplified simultaneously in the same reaction well. Each target is distinguished by a probe labeled with a different fluorescent dye.
Among existing qPCR reaction systems, the TaqMan™ probe-based method is particularly suitable for multiplex qPCR. Because the probe itself provides high specificity, and each probe can be paired with a different fluorescent dye, individual target sequences can be distinguished by different fluorescent signals.
This dual advantage enables researchers to amplify multiple assays in a single reaction while accurately detecting each target independently.
Why Choose Multiplex qPCR?
Compared with singleplex qPCR, multiplex qPCR offers several significant advantages:
Higher throughput: More targets can be detected in each well, improving the overall efficiency of the entire reaction plate.
Lower reagent and sample consumption: Multiplex qPCR allows more efficient use of costly reagents and limited biological samples.
Greater precision and reliability: Multiplex qPCR allows the target sequence and internal control to be analyzed in the same reaction well. This helps reduce well-to-well variation and improves data comparability and reliability.
In many cases, starting with duplex qPCR is a practical first step. As the technology continues to advance, the advantages of multiplex qPCR become even more significant when three or more targets are combined in a single reaction.
With advanced tools, services, and product support from Thermo Fisher Scientific, higher-order multiplex qPCR, with up to six targets, is now increasingly achievable.
When Is Multiplex qPCR Most Useful?
Multiplex qPCR is especially valuable in the following situations:
When the same set of assays needs to be applied to a large number of samples.
When high data quality and strict quality control are required.
When sample volume is limited or the sample is especially precious.
When a study requires the detection of many targets, for example more than 12 targets, a real-time PCR array may be considered to improve overall analysis efficiency.
As the number of targets in a multiplex reaction increases, especially from three to six targets, the complexity of experimental design also increases significantly. In such cases, technical application scientists (TAS) and field application scientists (FAS) can provide professional guidance.
How to Design a Successful Multiplex qPCR Experiment
A successful multiplex qPCR workflow requires careful experimental design and thorough testing. Key considerations include the following:
Selecting Compatible Assays
The first step is to determine which assays you would like to combine. The achievable level of multiplexing depends on the number of optical detection channels available on the qPCR instrument. For example, if the instrument has six detection channels, it can theoretically detect up to six targets simultaneously.
The Multiplexing Support Request Tool in the qPCR Assay Design Hub can be used to evaluate assay compatibility. A multiplex analysis support team can also provide in silico analysis to help assess whether primers or probes may interfere with one another.
Selecting Appropriate Fluorescent Dyes
Proper dye selection helps achieve clear spectral separation between targets.
Recommended dyes include FAM, VIC, ROX, Cy5, Cy5.5, and Cy3. Most Applied Biosystems™ reagents contain the passive reference dye ROX™, which is especially beneficial in multiplex qPCR.
The Q9600 Series supports multiplex qPCR experiments without requiring a ROX channel. Users may select the appropriate fluorescent dyes according to their experimental needs, without additional dye calibration.
Optimizing Primer Concentration
In singleplex TaqMan assays, a uniform primer concentration of 900 nM is typically recommended.
However, in multiplex reactions, using the same concentration for all primer pairs may cause high-abundance targets to amplify rapidly. This may lead to depletion or saturation of Taq DNA polymerase, thereby suppressing the amplification of low-abundance targets.
To avoid this situation, primer-limiting strategies may be applied to selected assays.
Researchers should determine which assays require primer limitation based on the expected abundance of each target.
Under standard conditions, high-abundance targets may quickly reach polymerase saturation and enter the linear amplification phase. Low-abundance targets may then also be forced into the linear phase, resulting in inaccurate Ct values or even failed detection.
By limiting primer concentration, amplification enters the linear phase due to primer depletion rather than polymerase saturation. This helps ensure that low-abundance targets remain in the exponential amplification phase.
VIC-labeled, primer-limited (PL) gene expression assays are available. Custom TaqMan™ Gene Expression Assays and specialty oligonucleotide synthesis services can also provide different dye and PL format options.
Performance Testing Before Scale-Up
Before multiplex qPCR is formally applied, its performance must be verified.
A more stringent approach is to use mixed standard curves. In this method, one target is serially diluted while a fixed amount of a second target is added. The mixed samples are then amplified by real-time PCR. Ideally, both targets should maintain good linearity across the full detection range.
For triplex or higher-order multiplex reactions, multiple target combinations should be tested.
A simplified approach is to run singleplex and multiplex amplification on the same set of samples, and then compare the consistency of the results.
Integrating Multiplex Assays into a Single-Tube Reagent Format
If the performance verification results of the multiplex qPCR assay are satisfactory, all assays can be premixed into a single-tube format using specialty oligonucleotides.
This approach offers several advantages:
It simplifies reaction setup.
It helps ensure consistent primer and probe ratios.
It improves experimental reproducibility.
More Exhibitor's Press Release
- LabWare Named Best IT Solution at the Labmate Awards for Excellence 2025 LABWARE TAIWAN CO., LTD. / 2026-06-22
- Next Generations Therapy Manufacturing LEVITRONIX GMBH TAIWAN BRANCH / 2026-06-17
- The Fastest and Safest Depth Filtration LEVITRONIX GMBH TAIWAN BRANCH / 2026-06-17
- Highest Cell Viability in Perfusion LEVITRONIX GMBH TAIWAN BRANCH / 2026-06-17
- Wireless × Complete Recording × Traceability BrainChild DRS Powers Smarter Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-06-16
- BrainChild PRV2.0 Precision Measurement Built for Accuracy, Reliability and Better Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-06-16
- BrainChild XH13 Cloud Logger Delivers Environmental Visibility for Labs and Storage BRAINCHILD ELECTRONIC CO., LTD. / 2026-06-16
- Bridging the U.S. and Global Markets: EG BioMed Builds an International Precision Cancer Testing Ser EG BIOMED US INC. / 2026-06-15
- Blood-Based Early Cancer Detection: Advancing Precision Health Through DNA Methylation Science EG BIOMED US INC. / 2026-06-15
- EG BioMed U.S. CLIA/CAP-Certified Laboratory Opens Partnership Opportunities EG BIOMED US INC. / 2026-06-15
- 2026 BIO Asia: Next-Gen 3D Cell Culture & Exosome Solutions by LIS TECH & GeniCore Biotech LIS TECH CO., LTD. / GENICORE BIOTECH / 2026-06-04
- Botanical Drug GM-XANTHO® Completes Phase I/IIa Trial for Atopic Dermatitis XANTHO BIOTECHNOLOGY CO., LTD. / 2026-06-04
- ProBio and Curocell Achieve Key CAR-T Milestone with BLA Regulatory Approval and Commercial Readines PROBIO TECHNOLOGY HK LIMITED. / 2026-06-04
- LIS TECH Showcases Regenerative Medicine and Bioprocessing Platform at BIO Asia–Taiwan 2026 LIS TECH CO., LTD. / GENICORE BIOTECH / 2026-06-03
- GeniCore Biotech Unveils Its AI-Powered Genimer™ Aptamer Platform LIS TECH CO., LTD. / GENICORE BIOTECH / 2026-06-03
- Medidata’s Digital Oversight Platform Empowers Pharma and CROs to Align with Next-Gen GCP MEDIDATA / 2026-06-02
- Medidata Powers Transformational Breakthroughs in Over 500 Global Clinical Trials with AI MEDIDATA / 2026-06-02
- Empowering eCOA to Deliver Flexible and Efficient Digital Solutions MEDIDATA / 2026-06-02
- Save the Date: LabWare Professional Seminar Coming This September! LABWARE TAIWAN CO., LTD. / 2026-05-29
- SimTissue® by Lyson: The One-Stop Phantom Solution for Advanced Surgical Simulation LYSON MEDICAL TECHNOLOGY / 2026-05-27
